CARDIFF ONCOLOGY INC. - COMMON STOCK

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

23 4 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

15 4 2025 16:10:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

15 4 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

27 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences

24 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

20 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering

10 12 2024 07:20:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial

10 12 2024 06:00:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC

19 11 2024 08:00:01 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update

07 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC

30 10 2024 16:30:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

08 8 2024 16:05:01 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update

01 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at the Jefferies Healthcare Conference

29 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences in May

13 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update

02 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

25 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

08 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024

06 3 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

29 2 2024 16:07:00 提供 Nasdaq GlobeNewswire